Date of Award
Bachelor of Science (B.S.) in Computer Science and University Honors
Myc oncogenes, Genetic transcription, Transcription factors, Cancer -- Treatment
A systematic review of the available studies on the interference of OmoMyc with Myc's function in cancerous cells is presented. Myc is a transcription factor that regulates cellular processes such as apoptosis, proliferation, and differentiation. However, Myc is often overexpressed in a variety of cancers, resulting in abnormal growth of cancer cells. Although the inhibition of Myc has been highly desired, it remained a challenge due to its undruggable characteristics. Attempts to inhibit Myc have involved the usage of small-molecules, but these attempts have failed, causing adverse effects and incomplete inhibition of Myc. Despite promising preclinical studies of OmoMyc, it is only considered as a proof of principle due to the difficulties to deliver into cells. The results of this systematic review are discussed in hopes of overcoming difficulties in the delivery of OmoMyc in vitro transcribed mRNA (IVT-mRNA) in efforts to inhibit the overexpression of Myc.
In Copyright. URI: http://rightsstatements.org/vocab/InC/1.0/ This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).
McGraw, Angie, "Inhibition of Cancer Causing Genes Through the Delivery of OmoMyc in Anti-Myc Therapy: a Systematic Review" (2020). University Honors Theses. Paper 874.